Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPANC-2 trials.

Quisette P Janssen,Rutger Quispel,Marc G Besselink,Bert A Bonsing,Marco J Bruno,Michael Doukas,Arantza F Sarasqueta,Marjolein Y V Homs,Jeanin E van Hooft,Geertjan van Tienhoven,Marie-Louise F van Velthuysen,Joanne Verheij,Rogier P Voermans,Johanna W Wilmink,Bas Groot Koerkamp,Casper H J van Eijck,Lydi M J W van Driel

HPB : the official journal of the International Hepato Pancreato Biliary Association（2023）

引用 1|浏览27

暂无评分

摘要

EUS-guided TA of patients with borderline resectable and resectable PDAC included in RCTs had an SFM above 85% for both first and repeat procedures, meeting international standards. Two percent had false positive result for malignancy and 5% had other (non-PDAC) periampullary cancers.

查看译文

关键词

pancreatic ductal adenocarcinoma,endoscopic tissue acquisition,diagnostic performance

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要